|Bid||0.00 x 800|
|Ask||0.00 x 900|
|Day's range||203.71 - 206.17|
|52-week range||141.41 - 210.10|
|Beta (5Y monthly)||0.65|
|PE ratio (TTM)||51.25|
|Earnings date||04 Nov 2021|
|Forward dividend & yield||1.00 (0.49%)|
|Ex-dividend date||28 Oct 2021|
|1y target est||224.58|
PARSIPPANY, N.J., October 18, 2021--Robert J. Polzer, PhD, will succeed current EVP and President of R&D at Zoetis, Dr. Catherine Knupp, DVM, MS.
PARSIPPANY, N.J., October 14, 2021--The Board of Directors of Zoetis Inc. has declared a fourth quarter 2021 dividend payable to holders of the company’s common stock of $0.25 per share.
Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.